PGY2 Infectious Diseases Residency
Site: VA St. Louis Health Care System
Available Position: 1
Residency Period: July 1-June 30 (tentative)
This program is designed to train residents to become clinical specialists and educators in the area of infectious diseases pharmacotherapy. Residents have required learning experiences in clinical microbial laboratory, infectious diseases, critical care, internal medicine and practice management. Residents will complete two elective rotations, one of which will occur at a partner institution in St. Louis.
Residents have the opportunity to participate in longitudinal learning experiences in the infectious diseases clinic, hepatitis clinic and Outpatient Parenteral Antimicrobial Therapy (OPAT) monitoring program. In the acute care setting, residents will round and provide direct patient care on multidisciplinary teams, participate in robust antimicrobial stewardship, adverse event reporting and prior approval programs.
In the ambulatory care setting, residents will provide direct patient care in both interdisciplinary and pharmacist-run clinics. Residents also receive experience in clinical intervention documentation, medication therapy management (MTM) and departmental committee service. Residents also receive substantial teaching experience through both experiential teaching opportunities at the College.
Ryan P. Moenster, Pharm.D, FIDSA, BCPS-AQ ID
Moenster is residency program director for the PGY2 Infectious Diseases Residency at the VA St. Louis Health Care System where he is a clinical pharmacy specialist in infectious diseases. He is currently an associate professor of pharmacy practice and interim director of the Division of Specialty Care Pharmacy at St. Louis College of Pharmacy. Moenster earned his Doctor of Pharmacy degree (Pharm.D.) from St. Louis College of Pharmacy. Subsequently, he completed his Pharmacy Practice and Internal Medicine Specialty Residencies at VA St. Louis Health Care System-John Cochran through St. Louis College of Pharmacy. He is a Board Certified Pharmacotherapy Specialist (BCPS) with added qualification in Infectious Diseases (BCPS – AQ ID). He is recognized as a Fellow of the Infectious Disease Society of America (FIDSA).